As winter has come already, so does the other wave of COVID-19. However, the situation is a bit serious but a bit different. Yes, the race of vaccines across the globe. Currently, FDA has approved vaccines (derived by Pfizer and BioNTech) as safe, and a few months back, the UK has made Pfizer’s vaccine applicable to use among their population. About one or two months back, Pfizer and BioNTech came up with a vaccine of 95 percent efficacy in Clinical Trial Phase III and got approved. The vaccine, unlike previous others, is an mRNA, which was found to be stored at -70 C and expensive. However, as mentioned, FDA has now approved Pfizer’s vaccine but the question remains: Is it applicable to our population? As reported on Pfizer’s official site, 150 Clinical Trials were conducted in 6 countries, which comprises the United States, Germany, South Africa, Turkey, Argentina and Brazil. Among this trial, 40 percent were of diverse races and out of which,5 percent were of Asians. About few days
